Paul Neeson

29PUBLICATIONS
161CO-AUTHORS
Radiation therapyTumour immunologyPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Aug 26, 2026
Single-fraction or multi-fraction stereotactic ablative body radiotherapy followed by atezolizumab in advanced triple-negative breast cancer: a randomized phase II trial.

|Jul 30, 2026
Breast implant associated anaplastic large cell lymphoma is a heterogeneous T cell disease with active pro-tumour cross-talk and immune suppression.

|Jul 08, 2026
Dynamic immune profiling predicts response to radiation plus anti-PD-1 therapy in oligometastatic renal cell carcinoma.

|Jun 19, 2026
Recurrent intra-tumour heterogeneity is a hallmark of metastatic prostate cancer.

|Jun 11, 2026
Tumor-resident T cells and dendritic cells form an in situ archetype during immunotherapy response in melanoma.

|Nov 07, 2025
Bispecific antibody combination therapies in diffuse large B-cell lymphoma.

Sean Harrop, Adrian Minson, Thiago M Steiner

Pageof 5

Frequent Collaborators

7 joint publications

Phillip K Darcy

6 joint publications

Minyu Wang

5 joint publications

Angela Pizzolla

5 joint publications

Kevin Sek